Literature DB >> 1707021

Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis.

R D Curran1, F K Ferrari, P H Kispert, J Stadler, D J Stuehr, R L Simmons, T R Billiar.   

Abstract

Hepatocytes are stimulated to produce nitric oxide (NO.) from L-arginine in response to conditioned Kupffer cell medium or a combination of cytokines. Associated with the production of NO.in hepatocytes, there is a profound decrease in total protein synthesis ([3H]leucine incorporation). This report demonstrates that authentic NO.and the NO.-generating compound S-nitroso-N-acetylpenicillamine inhibit hepatocyte total protein synthesis in a reversible and concentration-dependent fashion. In parallel with the suppression of hepatocyte total protein synthesis, authentic NO.inhibits the production of two specific hepatocyte proteins, albumin and fibrinogen, without influencing the quantity of albumin mRNA. Although authentic NO.induces a rapid increase in cGMP levels in hepatocytes, the addition of the cGMP analog 8-bromoguanosine 3':5' cyclic monophosphate to unstimulated HC cultures does not reproduce the inhibition of total protein synthesis. These data show that NO.is the hepatocyte L-arginine metabolite that inhibits protein synthesis. Furthermore, these findings indicate that NO.does not inhibit hepatocyte protein synthesis solely through the activation of soluble guanylate cyclase but appears to affect a translational or posttranslational process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707021     DOI: 10.1096/fasebj.5.7.1707021

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  35 in total

1.  The effect of lymphatic blockage on the amount of endotoxin in portal circulation, nitric oxide synthesis, and the liver in dogs with peritonitis.

Authors:  O Güler; S Uğraş; M Aydin; F H Dilek; O N Dilek; M Karaayvaz
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Nitric oxide inhibition of coxsackievirus replication in vitro.

Authors:  C Zaragoza; C J Ocampo; M Saura; A McMillan; C J Lowenstein
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

3.  Cholera toxin-sensitive GTP-binding protein-coupled activation of augmenter of liver regeneration (ALR) receptor and its function in rat kupffer cells.

Authors:  Chandrashekhar R Gandhi; Noriko Murase; Thomas E Starzl
Journal:  J Cell Physiol       Date:  2010-02       Impact factor: 6.384

4.  Regulation of hepatocyte albumin and alpha 1-acid glycoprotein secretion by monokines, dexamethasone, and nitric oxide synthase pathway: significance of activated liver nonparenchymal cells.

Authors:  Y Itoh; T Okanoue; F Enjo; S Sakamoto; S Takami; K Yasui; K Kagawa; K Kashima
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

Review 5.  The multiple actions of NO.

Authors:  Yuansheng Gao
Journal:  Pflugers Arch       Date:  2009-12-19       Impact factor: 3.657

6.  Vascular gene transfer of the human inducible nitric oxide synthase: characterization of activity and effects on myointimal hyperplasia.

Authors:  E Tzeng; L L Shears; P D Robbins; B R Pitt; D A Geller; S C Watkins; R L Simmons; T R Billiar
Journal:  Mol Med       Date:  1996-03       Impact factor: 6.354

7.  Inhibition of protein synthesis by nitric oxide correlates with cytostatic activity: nitric oxide induces phosphorylation of initiation factor eIF-2 alpha.

Authors:  Y M Kim; K Son; S J Hong; A Green; J J Chen; E Tzeng; C Hierholzer; T R Billiar
Journal:  Mol Med       Date:  1998-03       Impact factor: 6.354

8.  Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): potential role of cyclin D1.

Authors:  S Pervin; R Singh; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

9.  Inhibition of cytochromes P4501A by nitric oxide.

Authors:  J Stadler; J Trockfeld; W A Schmalix; T Brill; J R Siewert; H Greim; J Doehmer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Pronounced enhancement of .NO-dependent antimicrobial action by an .NO-oxidizing agent, imidazolineoxyl N-oxide.

Authors:  K Yoshida; T Akaike; T Doi; K Sato; S Ijiri; M Suga; M Ando; H Maeda
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.